Dec 20 Glaxosmithkline Plc
* First phase iii studies to show efficacy of two-drug regimen as maintenance therapy
* Viiv healthcare announces positive results from first phase iii studies of two-drug hiv treatment regimen Source text for Eikon: Further company coverage: (Reporting By UK Bureau)
ChargePoint secures $43 million in funding led by Siemens
SAN FRANCISCO, June 28 Electric vehicle charging station maker ChargePoint Inc said on Wednesday it had secured $43 million in financing led by German engineering group Siemens AG, bringing to a close the U.S. company's latest funding round at $125 million.